NCT02323854View on ClinicalTrials.gov

The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)

NACompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

March 13, 2017

Study Completion Date

November 30, 2017

Conditions
Lung Cancer
Interventions
DEVICE

Ablation

Percutaneous antenna will be placed into the target tumor under CT image guidance. Target tumor will be ablated and the antenna will be removed.

PROCEDURE

Surgical Resection

The planned surgical resection of the lung tumor will be conducted as scheduled post ablation procedure.

Trial Locations (4)

10065

Weill Cornell Medical College, New York

55905

Mayo Clinic, Rochester

60590

University Hospital Frankfurt, Frankfurt

02903

Rhode Island Hospital, Providence

Sponsors

Lead Sponsor

Medtronic - MITG
All Listed Sponsors
lead

Medtronic - MITG

INDUSTRY